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Two main methods have been used in the in vitro study of allograft rejection: 
mixed lymphocyte cultures (MLC) and cell-mediated lympholysis (CML). Be- 
cause the proliferative phase in MLC does not necessarily provoke the genera- 
tion of cytotoxic T lymphocytes (1), the CML assay is considered to be a better 
model of allograft rejection. The generation of cytetoxic effector cells is depend- 
ent on major histocompatibility system (MHS) disparity between effector and 
target cells (2, 3). Some sensitive CML assays have recently enabled the detec- 
tion ofcytotoxic  T cells activated against the H-2 antigenic specificities alone (4); 
however, amplification of CML by added/-region disparity has been noted (2, 3, 
5). The I  region contains lymphocyte-activating  determinants (LADs) to which 
amplification has been attributed and LADs outside the MHS (6-8) have also 
been claimed to substitute for/-region LADs (9, 10). 
MLC tests are enhanced by preimmunization of donor animals across MHS 
barriers (11, 12), but are suppressed when preimmunized  with M-locus incompat- 
ibility (6, 13). 
The aim of the present experiments is to examine the effects of H-2 and M- 
locus preimmunization on the generation in MLC of effector cells assayed by 
CML. 
Materials and Methods 
Mice.  Adult female mice of the following inbred strains and F~ hybrids were used: CBA/H (H- 
2k,Mls~),  BRVR (I-I-2k,Mls"), BALB/c (H-2~,Mls~), DBA/2  (H-2d,Mls"),  and (CBA/H  x  DBA/2)F1 
mice. 
Experimental Design.  Groups  of CBA/H  mice  were  immunized  intraperitoneally  with  107 
spleen  cells  from  (a)  BRVR  (M-locus  incompatible),  (b)  BALB/c  (/-/-2 incompatible),  and  (c) 
syngeneic cells. For certain experiments, groups (a) and (b) were given a second injection on day 6. 
At various times after immunization lymph node cells were removed from mice in each of the 
immunized groups and cultured with (CBA/H  x  DBA/2)F1 lymphocytes. The generation of cyto- 
toxic effector cells after a 5-day sensitization period was tested against phytohemagglutinin (PHA) 
transformed DBA/2, BRVR, and CBA/H as well as LPS-transformed BRVR lymphocytes. 
Mixed Lymphocyte  Cultures.  Axillary  lymph  nodes were  removed  from the preimmunized 
mice and from normal (CBA/H x  DBA/2)F1 mice, gently pushed through metal sieves of fine mesh 
and washed twice in Eagle's minimal essential medium (Wellcome Research Laboratories, Kent, 
England). The cells were then resuspended at a concentration of 5 x  106/ml in RPMI (Grand Island 
Biological  Co.,  Grand  Island,  N.  Y.)  medium  containing  glutamine  and  supplemented  with 
antibiotics,  10  mM  HEPES,  10%  fetal  calf serum,  and  5  x  10 -5  M  2-mercaptoethanol.  The 
responder and stimulator cell suspensions were mixed in equal proportion and dispensed in 200 t~l 
volumes into flat-bottomed wells of Cooke microtest II plates (Cooke M220-29AR, Cooke Labora- 
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tory  Products,  Alexandria,  Va.).  The  plates were  incubated  at 36°C in  partially  evacuated 
containers which were gassed with a mixture of 92% N2 and 8% COs, leaving a residual vacuum of 
100 mmHg and a gas mixture 86% N2, 10% 08, and 4% COs. 
Cell-Mediated Lymphocytotoxicity Assay (CML).  The assays were carried out as previously 
described (14). Briefly, effector cells from 5th day MLC were pooled and washed once before the 
assay. Target cells cultured for 2-3 days in the presnce of 1 /zg/ml PHA (Wellcome Research 
Laboratories)  were washed once and labeled with 100 tzCi s~Cr-sodium chromate, washed twice 
after labeling,  and  the  viable blasts reconstituted to 4  x  l0  s cells  per  ml.  The target  cell 
suspensions  were dispensed in 25-/~1 amounts into wells of Cooke microtest II plates; immune and 
normal effector cells were added in 200 tzl volumes to the target cells in proportions  of 20:1, 40:1, 
and 80:1 with triplicates at each ratio. To estimate maximum release 200 t~l distilled  water were 
added to the target cells. The plates were lightly spun for 5 min and incubated for 3 h at 36°C in a 
CO2 atmosphere. At the end of the incubation  period 50/zl of supernate were removed from each 
well for counting. Specific release of isotope was calculated according to the following formula: 100 
× [cpm (immune effectors) -  cpm (normal effectors)]/[maximum release -  cpm (normal effectors)]. 
Results 
Effect  of Preimmunization  on  the  Generation  of  Cytotoxic  Lymphocytes 
against H-2 Targets.  The effect of preimmunization of CBA/H mice with one 
injection  of BRVR  and  BALB/c  spleen  cells  on the  subsequent  generation  in 
vitro of effector cells against DBA/2 is shown in Table I. Sensitization in MLC 
initiated  3  days  after  immunization  resulted  in  enhanced  cytotoxic  activity 
against DBA/2 when the responder cells were obtained from either BALB/c (H-2 
incompatible) or BRVR (M-locus incompatible) immunized groups; the specific 
51Cr  release  was  approximately twice (2.39  and  1.96  times,  respectively) that 
produced by effectors derived  from syngeneic immunized control  mice.  When 
lymphocytes were removed for in vitro sensitization 6 days after immunization, 
effecters generated from the BALB/c immunized group retained their enhanced 
lytic  activity compared to  the  control  group.  Lymphocytes obtained  from the 
BRVR immunized group,  however, showed suppressed lytic activity on DBA/2 
targets. 
Suppression  of the  cytotoxic response reached  a  maximum  on the  15th  day 
after immunization and thereafter waned gradually. By the 28th day, enhance- 
ment of cytotoxicity was noted in both immunized groups. The enhanced cyto- 
toxic activity of the BALB/c immunized mice, noted 3 days after immunization, 
was relatively suppressed from the 6th to the 15th day, as shown in Fig.  1 and 
Table I, but a  net increase in lytic activity compared to the control group was 
maintained throughout the experimental period. 
A  second  injection  of l0  T spleen  cells  given  6  days  after the  first  injection 
resulted  in  abrogation  of cytotoxicity to  DBA]2  targets  in  the M-locus-immu- 
nized  mice  tested  on  the  15th  day  after  the  beginning  of the  immunization 
schedule (Table II). The small percentage specific release of isotope (3.8%) was 
found not to represent significant kill by an analysis of variance test.  Suppres- 
sion of cytotoxic response after the second injection was maintained for up to 60 
days after the beginning of immunization. 
Effect of Preimmunization  on  the  Generation  of Cytotoxic  T  Lymphocytes 
against M-locus Incompatible  Targets.  As we were previously unsuccessful  in 
generating effector cells in MLC against M-locus incompatible target cells, we 
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TABLE  I 
Cytotoxicity of  Effeetors from CBA/H Mice Preirnrnunized with Syngeneic, M Locus, and 
H-2-Incornpatible Cells and Cultured in vitro with (CBA/H  × DBA/2)F1 Cells 
Cells for in vitro  sen-  Lymphocytes removed from mice for MLC on days indicated after preimmunization  of 
sitization taken  mice: 
from CBA/H mice 
immunized against:  3  6  15  19  28 
% specific s~Cr  released from DBA/2 targets 
CBA/H  15.2 (1)*  20.6 (1)  20.1 (1)  28.7 (1)  17.1 (1) 
BRVR  29.8 (1.96)  11.I (0.53)  8.8 (0.44)  19.3 (0.67)  22.6 (1.32) 
BALB/c  36.1 (2.37)  29.2 (1.41)  28.7 (1.42)  54.6 (1.89)  62.7 (3.66) 
Differences  in  specific  5~Cr  release  between the  control  and test  immunized groups were significant  within  the 
range P < 0.026  toP < 0.001  estimated by analysis  of  variance  tests. 
Nonspecific  kill  estimated  by isotope  release  from CBA/H targets  in all experiments fell  in the range 0.02- 
1,65%. 
* The percent ~Cr release figures were transformed  by expressing them relative to the syngeneic control which 
thus became unity. 
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FIG.  i.  Time-course study of  the anti-H-2 cytotoxic behavior of  lymphocytes from CBA/H 
mice immunized with H-2-incompatible (A),  M-locus incompatible (e),  and syngeneic cells 
(- -) and sensitized in vitro against (CBA/H  x DBA/2)FI cells. 
removed  from preimmunized  mice  for in  vitro  sensitization  with  (CBA/H  × 
DBAJ2)F1 cells at various intervals after immunization,  and cytotoxic effectors 
against BRVR targets were assayed. Representative results are shown in Table 
III.  Sensitization  of syngeneically  immunized  CBA/H  mice  against  M-locus 
disparate cells in presence of added H-2 incompatibility did not generate effec- 
tors against M-locus targets.  Similarly,  preimmunization of CBA/H mice with 
M-locus or H-2 incompatibilities was equally ineffective in providing a boost for 
the generation in vitro of effectors against M-locus targets.  This may indicate 
that clones reactive to M-locus and H-2 LADs are distinct, and there is no co-op- 
eration between such activated clones. 
Discussion 
Preimmunization of CBA/H mice with M-locus incompatible cells did not help 
to  generate  cytotoxic  effectors  in  MLR  against  the  same  M-antigen-bearing 
targets.  The  anti-H-2  response  of M-locus preimmunized  mice,  however,  was 
characterized by a short period of amplification followed by a suppressed phase 
(Fig.  1).  It has previously been shown that preimmunization  against M  locus 
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TABLE  II 
Cytotoxicity of Effectors from CBA/H Mice Preimmunized and 
Boosted on Day 6 with BRVR and BALB/c Cells and 
Subsequently Cultured In Vitro with (CBA]H  x  DBA/2)FI Cells 
Cells  for  in  vitro  sensi- 
tization  obtained from 
CBA/H mice immu- 
nized against: 
Lymphocytes removed from mice for MLC  on days indi- 
cated after  preimmunization: 
15  30  60 
%  specific 5~Cr release  from DBA/2 targets 
CBA/H  18.6 (1)*  22.2 (1)  23.6 (1) 
BRVR  3.8 (0.20)  13.0 (0.58)  19.2 (0.81) 
BALB/c  26.6 (1.43)  37.3 (1.68)  44.5 (1.68) 
Differences in specific  5~Cr release between the control and test immunized 
groups were significant  within the range P  < 0.025 to  P  <  0.001 estimated by 
analysis of  variance tests. 
Nonspecific kill  estimated by isotope  release  from CBA/H in  all  experiments fell 
in the range of  0.02-1.65%. 
* The percent 5LCr  release  figures  were transformed by  expressing them relative  to 
the syngeneic control  which thus became unity. 
TABLE  III 
Effect of Preimmunization on the Interaction of M Locus and H-2- 
Activated Clones in the Generation of Effectors Against M-Locus 
Targets 
Cells for in vitro sensi- 
tization taken from 
CBA/H mice immu- 
nized against: 
Lymphocytes taken from mice for in vitro sensitization with 
(CBA/H x  DBAJ2)F1 cells on days indicated after preimmuniza- 
tion: 
3  6  15  19 
%  specific SlCr release  from BRVR targets 
CBA/H  1.83  1.72  2.04  2.16 
BRVR  0.22  0.88  1.12  3.55 
BALB/c  0.95  1.54  2.23  1.06 
All  5~Cr release data  do not  represent  significant kill as  determined  by  analysis 
of variance tests. 
$ PHA transformed; similar results were found with LPS-transformed targets. 
finding that has been confirmed and extensively studied by Jacobsson et al. and 
Lillieh6~k et al.  (13,  15, 16); not only did they find that there was a suppressed 
MLR, but also a weak GVHR (17). It is not surprising, therefore, that preimmu- 
nization against M  locus did not produce a  consistent heightened reaction in a 
time-course study as was noted in the case of H-2 preimmunization. 
The suppression of response of H-2 antigens in M  locus pre" mmunized mice 
cannot  satisfactorily  be  explained  by  a  pre-emption  process  of totipotential 
clones,  as we suspect that  different clones are activated by H-2-  and M-locus 
LADs. Nevertheless, we have somehow to explain how the immunization by one 
genetic determinant  suppresses the response to another.  This could either be 
through the release of a factor (18) that suppresses the activation or through cell 
contact between a  suppressor clone and the potentially activated clone causing 
negative co-operation or pre-emption by immune distraction,  so "instead of co- 
operating  with helper T  cells to produce effectors, the prekiller  cell interacts 
with suppressor cells which inactivate  it and prevent it from generating cyto- 
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In  the  time-course  study of the  effect of preimmunization an  interesting 
resemblance was noted in the pattern of anti-H-2 cytotoxicity produced by H-2 
complex LADs and M  locus--there was a  relative decline in the efficiency of 
amplification  by H-2 at the same time as the maximum suppressive action of  the 
M-locus preimmunized lymphoid population. Moreover, periods of amplification 
produced by beth types of immunization coincided. These observations imply 
that the immune response to beth M locus and H-2 antigens is the integration of 
two opposing components, i.e. amplification and suppression, the latter compo- 
nent being predominant in the M-locus-immunized mice. The possibility also 
arises that M  locus and H-2  LADs are heterogeneous; one or more H-2 LADs 
may act as helpers for heightened reactivity, while others may be suppressive. 
Similarly, genes associated with the M locus may code for determinants predomi- 
nantly suppressive in function. Experiments are in progress to examine these 
possibilities. 
Summary 
The effect of  preimmunization of  CBA/H mice with M locus and H-2 incompati- 
ble lymphocytes was examined on the in vitro generation of cytotoxic cells to 
beth types of targets. Preimmunization with M  locus did not help to generate 
cytotoxic cells to M-locus targets; however, the anti-H-2 cytotoxicity  of  M-locus- 
preimmunized lymphocytes was suppressed between the 6th and 19th day after 
preimmunization. In contrast, preimmunization with H-2  incompatibility pro- 
duced an amplified lytic anti-H-2 response. The possible mechanisms are dis- 
cussed. 
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